Medical Advocates
HIV Infection/Disease
  Cardiovascular Disease Risk
Factors
General Reports
 Atherosclerosis
 Fat Redistribution
 ARV Drugs
 Low-Density Lipoprotein
Cocaine
 Methamphetamines
 Lipodystrophy
 


 
HIV Cardiovascular Main Page Main New/Newsworthy Home Page      
Last Update: November 18, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       

          Journal Papers, Abstracts, and Commentaries

 
Abstract
Coronary and peripheral endothelial function in HIV patients studied with positron emission
tomography and flow-mediated dilation: relation to hypercholesterolemia.
Lebech AM, Kristoffersen US, Wiinberg N, et al 
J Nucl Med Mol Imaging. 2008 Jul 26
 Abstract
 
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice:
Results from the SIMONE study.
De Socio GV, Parruti G, Quirino Tm et al
J Infect. 2008 Apr 22
Abstract
 
HIV, AIDS and the cardiovascular risk
Neumann T.
Internist (Berl). 2008 Feb 29
 Abstract
 
ARTICLE
 Cardiovascular Risk and Risk Management in HIV-infected Patients.
Adeyemi O.
Top HIV Med. 2007 Nov-Dec;15(5):159-62.
 Paper

Ten-year predicted coronary heart disease risk in HIV-infected men and women
Kaplan RC, Kingsley LA, Sharrett AR, et al
Clin Infect Dis. 2007 Oct 15;45(8):1074-81
 Abstract
 
Global Cardiovascular Risk in Patients with HIV Infection: Concordance and Differences in
Estimates According to Three Risk Equations (Framingham, SCORE, and PROCAM).
Knobel H, Jericó C, Montero M, et al
AIDS Patient Care STDS. 2007 Jul;21(7):452-7.
Abstract
 
Correlations Between Carotid IMT, Factor VIII Activity Level and Metabolic Disturbances: A
Cardio-Vascular Risk Factor in the HIV Positive Persons.
de Saint Martin L, Pasquier E, et al
Curr HIV Res. 2007 May;5(3):361-4.
 Abstract
 
Prevalence of cardiovascular risk factors in HIV-infected patients.
Jerico C, Knobel H, Sorli ML, et al
Rev Clin Esp. 2006 Dec;206(11):556-9.
 Abstract
 
Management of Dyslipidemia and Other Cardiovascular Risk Factors in HIV-Infected Patients:
Case-based Review.
 Aberg JA.Top HIV Med. 2006 Oct-Nov;14(4):134-9.
Abstract
 
Lipids, Metabolic Syndrome, and Risk Factors for Future Cardiovascular Disease among
HIV-infected Patients.
Umeh OC, Currier JS.
 Curr HIV/AIDS Rep. 2005 Aug;2(3):132-9.
 Abstract
 
Risk factors for myocardial infarction in HIV-positive patients.
Quiros-Roldan E, Torti C, et al  
Int J STD AIDS. 2005 Jan;16(1):14-8
 Abstract
 
Highly active antiretroviral therapy and the cardiovascular system: the heart of the matter.
Barbaro G.
 Pharmacology. 2003 Dec;69(4):1
 Abstract
 
Acquired Immunodeficiency Syndrome and the Risk of Stroke.
Cole JW, Pinto AN, Hebel JR , et al
Stroke. 2003 Dec 18
Abstract

Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does
immune competence affect cardiovascular risk?
Nolan D, Watts GF, Herrmann SE
QJM. 2003 Nov;96(11):825-832.
 Abstract
 
Risk factors for coronary heart disease in patients treated for human immunodeficiency
 virus infection compared with the general population.
Saves M, Chene G, Ducimetiere P.
Clin Infect Dis. 2003 Jul 15;37(2):292-8.
 Abstract

          Conference Reports, Abstracts, and Posters

Risk for Cardiovascular Disease and Regional Adipose Tissue Depots among
HIV-infected Men and Women in the Study of Fat Redistribution and Metabolic
Changes in HIV Infection
Da Wohl, J Currier, E Madden, et al
(15 CROI)
 Abstract
 
Cardiovascular screening in HIV disease in the United Kingdom who does it and how?
C Stradling
(8th Int Congress on Drug Therapy in HIV Infection)
 Abstract
 
Use of Framingham Risk Score and diagnosis of Metabolic Syndrome to identify HIV patients
with a high cardiovascular risk profile in clinical practice: an Italian multicentric experience
G VL De Socio, G Madeddu, M Franzetti, et al
(8th Int Congress on Drug Therapy in HIV Infection)
 Abstract
 
Cardiovascular risk factors in HIV infected women from the Spanish VACH cohort
MJ Galindo, P Geijo, ML Garcia-Alcalde, et al
(8th Int Congress on Drug Therapy in HIV Infection)
 Abstract
 
Comparison of apolipoprotein B with conventional cardiovascular risk factors in adults with HIV+ |
infection
Stambullian M., Feliu M.S., Cassetti I., Slobodianik N.  
 (XVI International AIDS Conference)
 Abstract
 
Short-term results after pharmacological and lifestyle intervention in the cardiac risk of an
HIV positive population
Pai C.Y., Calderaro D., de Oliveira Lima E., et al
 (XVI International AIDS Conference)
 Abstract
 
Cardiac risk in HIV positive patients: A new group for aggressive prevention of atherosclerosis?
Pai C.Y., Calderaro D., de Oliveira Lima
 XVI International AIDS Conference)
 Abstract
 
POSTER
Analysis of Cardiovascular Risk Factors in the HIV Outpatient Study Cohort
K Lichtenstein, C Armon, K Buchacz, et al
(13 CROI)
PDF Poster     Abstract
 
The Effect of HAART Initiation on Blood Pressure
E Seaberg , S Riddler, J Margolick, et al
(12 CROI)
Abstract
 
Risk of Cardiovascular Disease in HIV-infected Adults with Immune Reconstitution
P  Williams, J Wu, S Coh, et al
(12 CROI)
Abstract
 
Lack of Evidence of Abnormal Myocardial Perfusion in HAART-treated, HIV-infected
Mexican Patients
Andres Catzin-Kuhlmann , A Orea, L Castillo, et al
(12 CROI)
Abstract
 
Hospitalizations for CHD and MI among Northern California HIV+ and HIV- Men-
Additional Follow-up and Changes in Practice
 D  Klein, L Hurley,  C Quesenberry, et al
(12 CROI)
Abstract
 
Factors Associated with a High Cardiovascular Risk in HIV-infected Patients in Spain:
A Multicenter, Nationwide, Cross-sectional Study
E Martinez, J Arribas, J López-Aldeguer, et al
(12 CROI)
Abstract
 
The Changing Face of Cardiovascular Risk in HIV-infected Patients. ANRS Aquitaine
Cohort, 2003
R Thiébaut, V Aurillac-Lavignolle, F Bonnet, et al
(12 CROI)
Abstract
 
Metabolic Syndrome and Markers of Early Atherosclerosis in a Cohort of HIV-infected
Subjects from Nutrition for Healthy Living
A Mangili, D Jacobson, J Gerrior, et al
(12 CROI)
Abstract
 
High Prevalence of Subclinical Atherosclerosis in Low Cardiovascular Risk HIV
Patients on HAART
H Knobel, A Guelar, C Jericó,  et al
(12 CROI)
Abstract
 
Rapid Progression of Carotid Lesions in HAART-treated HIV-1 Patients
P Maggi, F Perilli, A Lillo, et al
(12 CROI)
Abstract
 
C-reactive Protein Levels in Patients with HIV: A Marker of Cardiovascular Risk or
Chronic Infection?
P Hsue, J Lo, A Franklin, N Younes, et al
(12 CROI)
Abstract
 
Hypertriglyceridemic Waist Syndrome-associated Parameters Identify Markers of
Increased Cardiovascular Risk in HIV+ Treated Males
J Falutz  L Rosenthall
(12 CROI)
Abstract
 
Changes Over Time in the Use of Antiretroviral Therapy and Risk Factors for
Cardiovascular Disease in the D:A:D Study
C Sabin, LM, N Friis-Molle, M Rickenbach
(12 CROI)
Abstract
 
POSTER
 Risk Factors for Cardiovascular Disease, Common, and Internal Carotid Artery Intima-
Media Thickness and Coronary Calcium Scores in a Cohort of HIV-infected Subjects
from Nutrition for Healthy Living
A Mangili,  J Gerrior, A Tang, et al
 (11 CROI)
 PDF Poster      Abstract
 
POSTER
 Protease Inhibitor Exposure Time and Risk of Cardiovascular Disease in HIV-infected
Patients
U Iloeje, Y Yuan, G L'Italien, et al
 (11 CROI)
 PDF Poster     Abstract
 
POSTER
 Cardiovascular Risk Related with Prevalence and Percentage of Stenosis of the Carotid
Atherosclerosis Plaques in HIV-infected Patients: the CAPE Study
 C Cipriano, P Mercié, E Balestrem et al.
 11 CROI)
 PDF Poster      Abstract
Fat Redistribution
       

    Journal Papers, Abstracts, and Commentaries

 
Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV
 lipodystrophy: a model of 'systemic steatosis'
 Balasubramanyam A, Sekhar RV, Jahoor F, et al  
Curr Opin Lipidol. 2004 Feb;15(1):59-6
 Abstract
 
Abnormal body fat distribution and type of antiretroviral therapy as predictors of
cardiovascular disease risk in HIV-infected patients
Ena J, Benito C, Llacer P, et al  
Med Clin (Barc). 2004 May 22;122(19):721-6.
 Abstract
 
Cardiovascular Implications of HIV-associated Dyslipidemic Lipodystrophy.
Sekhar RV, Jahoor F, Pownall HJ, et al 
Curr Atheroscler Rep. 2004 May;6(3):173-9.
 Abstract

Cardiovascular complications and increased levels of circulating modified low
density lipoprotein in HIV patients and patients with lipodystrophy.
Ronchini KR, Duarte AJ, Casseb JS, Gidlund M.
Braz J Med Biol Res. 2004 Jan;37(1):119-22
 Abstract

Prediction of Coronary Heart Disease Risk in HIV-Infected Patients with Fat
Redistribution.
Hadigan C, Meigs JB, Wilson PW, et al
Clin Infect Dis 2003 Apr 1;36(7):909-16
 Abstract

Sustained Benefits of Metformin Therapy on Markers of  Cardiovascular Risk in
Human Immunodeficiency Virus-Infected Patients with Fat Redistribution and
Insulin Resistance.
Hadigan C, Rabe J, Grinspoon S.
Clin Endocrinol Metab 2002 Oct 1;87(10):4611-4615
 Abstract
 
          Conference Reports, Abstracts, and Posters
 
  Risk for Cardiovascular Disease and Regional Adipose Tissue Depots among
HIV-infected Men and Women in the Study of Fat Redistribution and Metabolic
Changes in HIV Infection
Da Wohl, J Currier, E Madden, et al
(15 CROI)
 Abstract
ARV Drugs
       

ARV Drugs: General

           Journal Papers, Abstracts, and Commentaries

 
HIV Therapy, Metabolic Syndrome, and Cardiovascular Risk.
Pao V, Lee GA, Grunfeld C. et al 
Curr Atheroscler Rep. 2008 Feb;10(1):61-70
 Abstract
 
Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome and Cardiovascular Risk.
Barbaro G, Barbarini G. 
Chemotherapy. 2006 May 2;52(4):161-165
 Abstract
 
Protease inhibitor exposure and increased risk of cardiovascular disease in
HIV-infected patients.
Iloeje U, Yuan Y, L'italien G, et al
 HIV Med. 2005 Jan;6(1):37-44.
 Abstract
 
Abnormal body fat distribution and type of antiretroviral therapy as predictors of
cardiovascular disease risk in HIV-infected patients
Ena J, Benito C, Llacer P, et al  
Med Clin (Barc). 2004 May 22;122(19):721-6.
 Abstract
 
Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV
infection: implications for treatment.
Steinhart CR, Emons MF
AIDS Read. 2004 Feb;14(2):86-90, 93-5
 Abstract
 
Combination antiretroviral therapy and the risk of myocardial infarction.
Friis-Moller N, Sabin CA, Weber R, et al
 N Engl J Med. 2003 Nov 20;349(21):1993-2003.
Abstract
 
HIV infection, highly active antiretroviral therapy and the cardiovascular system.
Barbaro G. 
Cardiovasc Res. 2003 Oct 15;60(1):87-95.
 Abstract
 
Interventional cardiovascular procedures among HIV-infected individuals on
antiretroviral therapy 1995-2000.
Braitstein P, Yip B, Heath KV, et al.
AIDS. 2003 Sep 26;17(14):2071-2075.
Abstract
 
Cardiovascular disease risk factors in HIV patients - association with antiretroviral
therapy. Results from the DAD study.
Friis-Moller N, Weber R, Reiss P, et al
AIDS. 2003 May 23;17(8):1179-1193.
 Abstract

HIV infection, antiretroviral therapy and cardiovascular risk.
Barbaro G.
J Cardiovasc Risk 2002 Oct;9(5):295-300
 Abstract

          Conference Reports, Abstracts, and Posters

 
Cerebro- and cardiovascular events and cardiovascular mortality in HIV-infected patients were
significantly increased after the introduction of HAART
P Freitas, D Carvalho, T Costa, et al 
(8th Int Congress on Drug Therapy in HIV Infection)
 Abstract
 
An estimation of the impact of a treatment including tenofovir DF on lipid metabolism and
cardiovascular risk of patients with HIV infection
Le Pen C., Bouchez M., Trylesinski A., Monchecourt F.
 (XVI International AIDS Conference)
 Abstract
 
ART and Asymptomatic Ischemic Heart Disease in HIV-infected Adults: A Cross-sectional
Analysis of Patients Enrolling in the SMART Trial
A Carr B Grund, J Neuhaus, et al
(13 CROI)
Abstract

Effect of ART on heart function in HIV infected children
R Rosso, A Ferrazin, P Cassottana, et al
(15IAC)
 Abstract
 
  Impact of HAART on risk of cardiovascular disease: the Swiss HIV Cohort Study
TR Glass, C Ungsedhapand, M Battegay, et al
(15IAC)
 Abstract
 
Protease Inhibitors

           Journal Papers, Abstracts, and Commentaries
 
 
Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on
cardiovascular risk and life expectancy
Grover SA, Coupal L, Gilmore N, Mukherjee J. 
Am J Cardiol. 2005 Mar 1;
 Abstract
 
Increased risk of myocardial infarction with duration of protease inhibitor therapy in
HIV-infected men.
Mary-Krause M, Cotte L, Simon A, et al 
AIDS. 2003 Nov 21;17(17):2479-86.
 Abstract

FULL-TEXT ARTICLE
HIV protease inhibitors promote atherosclerotic lesion formation independent of
dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in
macrophages.  
Dressman J, Kincer J, Matveev SV, et al.
J Clin Invest 2003 Feb;111(3):389-97
 Paper

Protease inhibitors and cardiovascular outcomes in patients with HIV-1.
Holmberg SD, Moorman AC, Williamson JM, et al.
Lancet 2002 Nov 30;360(9347):1747-8
 Abstract

Do protease inhibitors increase the risk for coronary heart disease in patients with
HIV-1 infection?
Klein D, Hurley LB, Quesenberry CP Jr, Sidney S.
 J Acquir Immune Defic Syndr 2002 Aug 15;30(5):471-7
 Abstract

          Conference Reports, Abstracts, and Posters

 
A Color Doppler Ultrasonographic Comparative Study between Patients Treated
with PI-including Regimens vs NNRTI-including Regimens (Prevaleat Study)
 P Maggi, G Epifani, F Perilli, et al
 (11 CROI)
Abstract
 
POSTER
 Protease Inhibitor Exposure Time and Risk of Cardiovascular Disease in HIV-infected
Patients
U Iloeje, Y Yuan, G L'Italien, et al
 (11 CROI)
 PDF Poster     Abstract

Effects of Highly Active Antiretroviral Therapy (HAART) on Cardiac Function in
HIV-Infected Patients
(41 ICAAC)    
Abstract
Low-Density Lipoprotein (LDL)
       
          Conference Reports, Abstracts, and Posters
 
  CONFERENCE PDF POSTER
 Ezetimibe Combined with Low Dose Statin Effectively Lowers LDL in Protease Inhibitor
Treated Patients
Klibanov OM, Gaughan JP, Tedaldi EM, et al
(4th IAS Conference)
 Posters
Cocaine
       

         Journal Papers, Abstracts, and Commentaries 

  Human immunodeficiency virus 1 infection, cocaine, and coronary calcification.
Lai S, Lima JA, Lai H, Vlahov D. et al
Arch Intern Med. 2005 Mar 28;165(6):690-5.
 Abstract
Methamphetamines
       

         Journal Papers, Abstracts, and Commentaries        

  Heart disease, methamphetamine and AIDS.
Yu Q, Larson DF, Watson RR.  
Life Sci 2003 May 30;73(2):129-140
 Abstract
Lipodystrophy
       

         Journal Papers, Abstracts, and Commentaries        

  Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy.
Falasca K, Ucciferri C, Manzoli L, et a
lInt J Immunopathol Pharmacol. 2007 July-September;20(3):519-527.
 Abstract

HIV Cardiovascular Main Page Main New/Newsworthy Home Page      

HIV Cardiovascular Disorders Risk Factors